FOR IMMEDIATE RELEASE | Exhibit 99.1 |
METTLER-TOLEDO INTERNATIONAL INC. REPORTS
FOURTH QUARTER 2022 RESULTS
COLUMBUS, Ohio, USA – February 9, 2023 – Mettler-Toledo International Inc. (NYSE: MTD) today announced fourth quarter results for 2022. Provided below are the highlights:
•Reported sales increased 2% compared with the prior year. In local currency, sales increased 9% in the quarter as currency reduced sales growth by 7%.
•Net earnings per diluted share as reported (EPS) were $11.86, compared with $9.94 in the prior-year period. Adjusted EPS was $12.10, an increase of 15% over the prior-year amount of $10.53. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules.
Fourth Quarter Results
Patrick Kaltenbach, President and Chief Executive Officer, stated, “We finished the year with excellent sales growth in the fourth quarter, and benefited from very good broad-based growth across geographic regions and product categories. We were particularly pleased with the strong execution from our team as we capitalized on our sophisticated sales and marketing programs and innovative product portfolio. Strong sales growth, combined with benefits from our margin initiatives and good cost control contributed to excellent growth in Adjusted Operating Profit and Adjusted EPS, offsetting very significant currency headwinds.”
GAAP Results
EPS in the quarter was $11.86, compared with the prior-year amount of $9.94.
Compared with the prior year, total reported sales increased 2% to $1.058 billion. By region, reported sales increased 8% in the Americas, decreased 3% in Europe and decreased 1% in Asia/Rest of World. Earnings before taxes amounted to $325.0 million, compared with $286.0 million in the prior year.
Non-GAAP Results
Adjusted EPS was $12.10, an increase of 15% over the prior-year amount of $10.53.
Compared with the prior year, total sales in local currency increased 9% as currency reduced sales growth by 7%. By region, local currency sales increased 8% in the Americas, 9% in Europe and 9% in Asia/Rest of World. Adjusted Operating Profit amounted to $358.6 million, a 12% increase from the prior-year amount of $319.1 million.
Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.
Full Year Results
GAAP Results
EPS was $38.41, compared with the prior-year amount of $32.78.
Compared with the prior year, total reported sales increased 5% to $3.920 billion. By region, reported sales increased 11% in the Americas, decreased 5% in Europe and increased 7% in Asia/Rest of World. Earnings before taxes amounted to $1.071 billion, compared with $949.4 million in the prior year.
Non-GAAP Results
Adjusted EPS was $39.65, an increase of 17% over the prior-year amount of $34.01.
Compared with the prior year, total sales in local currency increased 11% as currency reduced sales growth by 6%. By region, local currency sales increased 12% in the Americas, 6% in Europe and 13% in Asia/Rest of World. Adjusted Operating Profit amounted to $1.192 billion, a 13% increase from the prior-year amount of $1.058 billion.
-1-
Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.
Outlook
The Company stated that forecasting remains challenging. Management cautions that market conditions are dynamic and changes to the business environment can occur quickly. There is uncertainty in the economic environment today, including the risk of recession in some countries, and management acknowledges that market conditions are subject to change. Based on today's assessment of market conditions, management anticipates local currency sales growth for the first quarter of 2023 will be approximately 6%, and Adjusted EPS is forecast to be $8.55 to $8.65, a growth rate of 9% to 10%. Included in the first quarter guidance is an estimated 6% headwind to Adjusted EPS growth due to adverse currency.
For the full year, management anticipates local currency sales growth in 2023 will be approximately 5%, and Adjusted EPS is forecast to be in the range $43.55 to $43.95, representing growth of approximately 10% to 11%. This compares with previous local currency sales growth guidance of approximately 5% and Adjusted EPS guidance of $42.00 to $42.40. Included in the 2023 guidance is an estimated 1% headwind to Adjusted EPS growth due to adverse currency.
While the Company has provided an outlook for local currency sales growth and Adjusted EPS, it has not provided an outlook for reported sales growth or EPS as it would require an estimate of currency exchange fluctuations and non-recurring items, which are not yet known.
Conclusion
Kaltenbach concluded, “I am very proud of the agility and execution our team demonstrated in 2022 as we faced unexpected challenges like the war in Ukraine, lockdowns in China, and significant supply chain and inflationary pressures. As we look ahead to this year, we expect continued uncertainty regarding the global economy and face challenging multi-year sales growth comparisons. I am confident that the diligent execution of our growth and productivity initiatives will again position us very well to gain market share and deliver solid financial results.”
Other Matters
The Company will host a conference call to discuss its quarterly results tomorrow (Friday, February 10) at 8:30 a.m. Eastern Time. To hear a live webcast or replay of the call, visit the investor relations page on the Company’s website at www.mt.com/investors. The presentation referenced in the conference call will be located on the website prior to the call.
METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control and manufacturing processes for customers in a wide range of industries including life sciences, food and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.
Statements in this press release which are not historical facts constitute “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934. You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties, including statements about expected revenue growth and long-term impacts of the COVID-19 pandemic and ongoing developments in Ukraine. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential” or “continue.” We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, customer demand, our competitive position, pricing, our supply chain, adequacy of our facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, planned research and development efforts and product introductions, capital expenditures, cash flow, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions and the impact of the COVID-19 pandemic and ongoing developments in Ukraine on our businesses. Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including the uncertain duration and severity of the COVID-19 pandemic and ongoing developments in Ukraine. See in particular “Factors Affecting Our Future Operating Results” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2021 and other reports filed with the SEC from time to time.
-2-
METTLER-TOLEDO INTERNATIONAL INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(amounts in thousands except share data)
(unaudited)
Three months ended | Three months ended | ||||||||||||||||||||||||||||
December 31, 2022 | % of sales | December 31, 2021 | % of sales | ||||||||||||||||||||||||||
Net sales | $ | 1,057,685 | (a) | 100.0 | $ | 1,037,239 | 100.0 | ||||||||||||||||||||||
Cost of sales | 425,545 | 40.2 | 430,106 | 41.5 | |||||||||||||||||||||||||
Gross profit | 632,140 | 59.8 | 607,133 | 58.5 | |||||||||||||||||||||||||
Research and development | 45,942 | 4.3 | 45,615 | 4.4 | |||||||||||||||||||||||||
Selling, general and administrative | 227,586 | 21.5 | 242,445 | 23.4 | |||||||||||||||||||||||||
Amortization | 16,542 | 1.6 | 16,934 | 1.6 | |||||||||||||||||||||||||
Interest expense | 16,805 | 1.6 | 11,541 | 1.1 | |||||||||||||||||||||||||
Restructuring charges | 1,753 | 0.2 | 2,520 | 0.2 | |||||||||||||||||||||||||
Other charges (income), net | (1,502) | (0.1) | 2,102 | 0.2 | |||||||||||||||||||||||||
Earnings before taxes | 325,014 | 30.7 | 285,976 | 27.6 | |||||||||||||||||||||||||
Provision for taxes | 59,180 | 5.6 | 55,105 | 5.3 | |||||||||||||||||||||||||
Net earnings | $ | 265,834 | 25.1 | $ | 230,871 | 22.3 | |||||||||||||||||||||||
Basic earnings per common share: | |||||||||||||||||||||||||||||
Net earnings | $ | 11.97 | $ | 10.08 | |||||||||||||||||||||||||
Weighted average number of common shares | 22,209,188 | 22,912,071 | |||||||||||||||||||||||||||
Diluted earnings per common share: | |||||||||||||||||||||||||||||
Net earnings | $ | 11.86 | $ | 9.94 | |||||||||||||||||||||||||
Weighted average number of common and common equivalent shares | 22,407,796 | 23,220,331 | |||||||||||||||||||||||||||
Note: | |||||||||||||||||||||||||||||
(a) | Local currency sales increased 9% as compared to the same period in 2021. | ||||||||||||||||||||||||||||
RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT | |||||||||||||||||||||||||||||
Three months ended | Three months ended | ||||||||||||||||||||||||||||
December 31, 2022 | % of sales | December 31, 2021 | % of sales | ||||||||||||||||||||||||||
Earnings before taxes | $ | 325,014 | $ | 285,976 | |||||||||||||||||||||||||
Amortization | 16,542 | 16,934 | |||||||||||||||||||||||||||
Interest expense | 16,805 | 11,541 | |||||||||||||||||||||||||||
Restructuring charges | 1,753 | 2,520 | |||||||||||||||||||||||||||
Other charges (income), net | (1,502) | 2,102 | |||||||||||||||||||||||||||
Adjusted operating profit | $ | 358,612 | (b) | 33.9 | $ | 319,073 | 30.8 | ||||||||||||||||||||||
Note: | |||||||||||||||||||||||||||||
(b) | Adjusted operating profit increased 12% as compared to the same period in 2021. |
-3-
METTLER-TOLEDO INTERNATIONAL INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(amounts in thousands except share data)
(unaudited)
Twelve months ended | Twelve months ended | ||||||||||||||||||||||||||||
December 31, 2022 | % of sales | December 31, 2021 | % of sales | ||||||||||||||||||||||||||
Net sales | $ | 3,919,709 | (a) | 100.0 | $ | 3,717,930 | 100.0 | ||||||||||||||||||||||
Cost of sales | 1,611,667 | 41.1 | 1,546,377 | 41.6 | |||||||||||||||||||||||||
Gross profit | 2,308,042 | 58.9 | 2,171,553 | 58.4 | |||||||||||||||||||||||||
Research and development | 177,122 | 4.5 | 169,766 | 4.6 | |||||||||||||||||||||||||
Selling, general and administrative | 938,461 | 23.9 | 943,976 | 25.4 | |||||||||||||||||||||||||
Amortization | 66,239 | 1.7 | 63,075 | 1.7 | |||||||||||||||||||||||||
Interest expense | 55,392 | 1.4 | 43,242 | 1.2 | |||||||||||||||||||||||||
Restructuring charges | 9,556 | 0.2 | 5,239 | 0.1 | |||||||||||||||||||||||||
Other charges (income), net | (9,320) | (0.1) | (3,106) | (0.1) | |||||||||||||||||||||||||
Earnings before taxes | 1,070,592 | 27.3 | 949,361 | 25.5 | |||||||||||||||||||||||||
Provision for taxes | 198,090 | 5.0 | 180,376 | 4.8 | |||||||||||||||||||||||||
Net earnings | $ | 872,502 | 22.3 | $ | 768,985 | 20.7 | |||||||||||||||||||||||
Basic earnings per common share: | |||||||||||||||||||||||||||||
Net earnings | $ | 38.79 | $ | 33.25 | |||||||||||||||||||||||||
Weighted average number of common shares | 22,491,790 | 23,129,862 | |||||||||||||||||||||||||||
Diluted earnings per common share: | |||||||||||||||||||||||||||||
Net earnings | $ | 38.41 | $ | 32.78 | |||||||||||||||||||||||||
Weighted average number of common and common equivalent shares | 22,718,290 | 23,457,630 | |||||||||||||||||||||||||||
Note: | |||||||||||||||||||||||||||||
(a) | Local currency sales increased 11% as compared to the same period in 2021. | ||||||||||||||||||||||||||||
RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT | |||||||||||||||||||||||||||||
Twelve months ended | Twelve months ended | ||||||||||||||||||||||||||||
December 31, 2022 | % of sales | December 31, 2021 | % of sales | ||||||||||||||||||||||||||
Earnings before taxes | $ | 1,070,592 | $ | 949,361 | |||||||||||||||||||||||||
Amortization | 66,239 | 63,075 | |||||||||||||||||||||||||||
Interest expense | 55,392 | 43,242 | |||||||||||||||||||||||||||
Restructuring charges | 9,556 | 5,239 | |||||||||||||||||||||||||||
Other charges (income), net | (9,320) | (3,106) | |||||||||||||||||||||||||||
Adjusted operating profit | $ | 1,192,459 | (b) | 30.4 | $ | 1,057,811 | 28.5 | ||||||||||||||||||||||
Note: | |||||||||||||||||||||||||||||
(b) | Adjusted operating profit increased 13% as compared to the same period in 2021. |
-4-
METTLER-TOLEDO INTERNATIONAL INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(amounts in thousands)
(unaudited)
December 31, 2022 | December 31, 2021 | |||||||||||||
Cash and cash equivalents | $ | 95,966 | $ | 98,564 | ||||||||||
Accounts receivable, net | 709,321 | 647,335 | ||||||||||||
Inventories | 441,694 | 414,543 | ||||||||||||
Other current assets and prepaid expenses | 128,108 | 108,916 | ||||||||||||
Total current assets | 1,375,089 | 1,269,358 | ||||||||||||
Property, plant and equipment, net | 778,600 | 799,365 | ||||||||||||
Goodwill and other intangible assets, net | 966,224 | 956,072 | ||||||||||||
Other non-current assets | 372,482 | 302,003 | ||||||||||||
Total assets | $ | 3,492,395 | $ | 3,326,798 | ||||||||||
Short-term borrowings and maturities of long-term debt | $ | 106,054 | $ | 101,134 | ||||||||||
Trade accounts payable | 252,538 | 272,911 | ||||||||||||
Accrued and other current liabilities | 789,139 | 772,493 | ||||||||||||
Total current liabilities | 1,147,731 | 1,146,538 | ||||||||||||
Long-term debt | 1,908,480 | 1,580,808 | ||||||||||||
Other non-current liabilities | 411,391 | 428,031 | ||||||||||||
Total liabilities | 3,467,602 | 3,155,377 | ||||||||||||
Shareholders’ equity | 24,793 | 171,421 | ||||||||||||
Total liabilities and shareholders’ equity | $ | 3,492,395 | $ | 3,326,798 | ||||||||||
-5-
METTLER-TOLEDO INTERNATIONAL INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(amounts in thousands)
(unaudited)
Three months ended | Twelve months ended | ||||||||||||||||||||||
December 31, | December 31, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Cash flow from operating activities: | |||||||||||||||||||||||
Net earnings | $ | 265,834 | $ | 230,871 | $ | 872,502 | $ | 768,985 | |||||||||||||||
Adjustments to reconcile net earnings to | |||||||||||||||||||||||
net cash provided by operating activities: | |||||||||||||||||||||||
Depreciation | 11,783 | 11,542 | 46,784 | 44,982 | |||||||||||||||||||
Amortization | 16,542 | 16,934 | 66,239 | 63,075 | |||||||||||||||||||
Deferred tax benefit | 31,398 | 6,635 | 26,517 | 563 | |||||||||||||||||||
Share-based compensation | 5,730 | 5,702 | 19,661 | 19,595 | |||||||||||||||||||
Increase in acquisition contingent consideration | — | 6,849 | — | 6,849 | |||||||||||||||||||
Other | — | 381 | — | 381 | |||||||||||||||||||
Increase (decrease) in cash resulting from changes in | |||||||||||||||||||||||
operating assets and liabilities | (27,644) | (37,808) | (172,636) | 4,395 | |||||||||||||||||||
Net cash provided by operating activities | 303,643 | 241,106 | 859,067 | 908,825 | |||||||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||||
Proceeds from sale of property, plant and equipment | 163 | 253 | 399 | 3,652 | |||||||||||||||||||
Purchase of property, plant and equipment | (32,028) | (37,784) | (121,241) | (107,580) | |||||||||||||||||||
Proceeds from government funding (a) | 1,000 | — | 29,670 | — | |||||||||||||||||||
Acquisitions | (12,363) | (27,475) | (37,951) | (220,862) | |||||||||||||||||||
Other investing activities | (6,809) | 2,123 | (10,272) | 10,682 | |||||||||||||||||||
Net cash used in investing activities | (50,037) | (62,883) | (139,395) | (314,108) | |||||||||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||||
Proceeds from borrowings | 786,195 | 789,198 | 2,307,256 | 2,427,519 | |||||||||||||||||||
Repayments of borrowings | (810,354) | (786,369) | (1,947,398) | (2,035,546) | |||||||||||||||||||
Proceeds from exercise of stock options | 13,756 | 5,549 | 33,216 | 20,463 | |||||||||||||||||||
Repurchases of common stock | (274,999) | (272,500) | (1,099,998) | (999,998) | |||||||||||||||||||
Acquisition contingent consideration payment | — | — | (7,912) | — | |||||||||||||||||||
Other financing activities | (31) | (123) | (1,203) | (2,987) | |||||||||||||||||||
Net cash used in financing activities | (285,433) | (264,245) | (716,039) | (590,549) | |||||||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | 5,657 | 914 | (6,231) | 142 | |||||||||||||||||||
Net increase (decrease) in cash and cash equivalents | (26,170) | (85,108) | (2,598) | 4,310 | |||||||||||||||||||
Cash and cash equivalents: | |||||||||||||||||||||||
Beginning of period | 122,136 | 183,672 | 98,564 | 94,254 | |||||||||||||||||||
End of period | $ | 95,966 | $ | 98,564 | $ | 95,966 | $ | 98,564 | |||||||||||||||
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW | |||||||||||||||||||||||
Net cash provided by operating activities | $ | 303,643 | $ | 241,106 | $ | 859,067 | $ | 908,825 | |||||||||||||||
Payments in respect of restructuring activities | 1,449 | 2,607 | 7,965 | 10,029 | |||||||||||||||||||
Proceeds from sale of property, plant and equipment | 164 | 253 | 399 | 3,652 | |||||||||||||||||||
Purchase of property, plant and equipment, net (a) | (32,474) | (37,784) | (93,131) | (107,580) | |||||||||||||||||||
Acquisition payments (b) | 72 | 462 | 2,678 | 2,706 | |||||||||||||||||||
Transition tax payment | — | 0 | 4,289 | 4,288 | |||||||||||||||||||
Adjusted free cash flow | $ | 272,854 | $ | 206,644 | $ | 781,267 | $ | 821,920 | |||||||||||||||
Notes: | |||||||||||||||||||||||
(a) In September 2021, the Company entered into an agreement with the U.S. Department of Defense to increase the domestic production capacity of pipette tips and enhance manufacturing automation and logistics. The Company will receive total funding of $35.8 million which will offset capital expenditures. For the three and twelve months ended December 31, 2022, funding proceeds of $1.0 million and $29.7 million, respectively, and related purchases of property, plant and equipment of $1.8 million and $28.1 million, respectively, are excluded from Adjusted free cash flow for the respective periods. | |||||||||||||||||||||||
(b) Includes $2.1 million of the PendoTECH contingent consideration payment that was reported in net cash provided by operating activities as required by U.S. GAAP for the twelve months ended December 31, 2022. |
-6-
METTLER-TOLEDO INTERNATIONAL INC.
OTHER OPERATING STATISTICS
SALES GROWTH BY DESTINATION | ||||||||||||||||||||||||||||||||||||||
(unaudited) | ||||||||||||||||||||||||||||||||||||||
Europe | Americas | Asia/RoW | Total | |||||||||||||||||||||||||||||||||||
U.S. Dollar Sales Growth | ||||||||||||||||||||||||||||||||||||||
Three Months Ended December 31, 2022 | (3%) | 8% | (1%) | 2% | ||||||||||||||||||||||||||||||||||
Twelve Months Ended December 31, 2022 | (5%) | 11% | 7% | 5% | ||||||||||||||||||||||||||||||||||
Local Currency Sales Growth | ||||||||||||||||||||||||||||||||||||||
Three Months Ended December 31, 2022 | 9% | 8% | 9% | 9% | ||||||||||||||||||||||||||||||||||
Twelve Months Ended December 31, 2022 | 6% | 12% | 13% | 11% | ||||||||||||||||||||||||||||||||||
RECONCILIATION OF DILUTED EPS AS REPORTED TO ADJUSTED DILUTED EPS | ||||||||||||||||||||||||||||||||||||||
(unaudited) | ||||||||||||||||||||||||||||||||||||||
Three Months Ended | Twelve months ended | |||||||||||||||||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||||||||||||||||
2022 | 2021 | % Growth | 2022 | 2021 | % Growth | |||||||||||||||||||||||||||||||||
EPS as reported, diluted | $ | 11.86 | $ | 9.94 | 19% | $ | 38.41 | $ | 32.78 | 17% | ||||||||||||||||||||||||||||
Purchased intangible amortization, net of tax | 0.21 | (a) | 0.21 | (a) | 0.87 | (a) | 0.70 | (a) | ||||||||||||||||||||||||||||||
Restructuring charges, net of tax | 0.06 | (b) | 0.09 | (b) | 0.34 | (b) | 0.18 | (b) | ||||||||||||||||||||||||||||||
Acquisition costs, net of tax | 0.01 | (c) | 0.26 | (c) | 0.03 | (c) | 0.35 | (c) | ||||||||||||||||||||||||||||||
Income tax expense | (0.04) | (d) | 0.03 | (d) | — | — | ||||||||||||||||||||||||||||||||
Adjusted EPS, diluted | $ | 12.10 | $ | 10.53 | 15% | $ | 39.65 | $ | 34.01 | 17% | ||||||||||||||||||||||||||||
Notes: | ||||||||||||||||||||||||||||||||||||||
(a) | Represents the EPS impact of purchased intangibles amortization of $6.1 million ($4.7 million net of tax) and $6.3 million ($4.8 million net of tax) for the three months ended December 31, 2022 and 2021, and of $25.5 million ($19.8 million net of tax) and $21.6 million ($16.3 million after tax) for the twelve months ended December 31, 2022 and 2021, respectively. | |||||||||||||||||||||||||||||||||||||
(b) | Represents the EPS impact of restructuring charges of $1.8 million ($1.4 million after tax) and $2.5 million ($2.0 million after tax) for the three months ended December 31, 2022 and 2021, and of $9.6 million ($7.8 million after tax) and $5.2 million ($4.2 million after tax) for the twelve months ended December 31, 2022 and 2021, respectively, which primarily include employee related costs. | |||||||||||||||||||||||||||||||||||||
(c) | Represents the EPS impact of a $6.8 million charge ($5.5 million after tax) to increase the PendoTECH acquisition contingent consideration and related obligations for the three and twelve months ended December 31, 2021. Also includes acquisition transaction costs of $0.2 million ($0.2 million after tax) and $0.6 million ($0.4 million after tax) for the three months ended December 31, 2022 and 2021, respectively, and of $0.9 million ($0.7 million after tax) and $3.4 million ($2.7 million after tax) for the twelve months ended December 31, 2022 and 2021, respectively. | |||||||||||||||||||||||||||||||||||||
(d) | Represents the EPS impact of the difference between our reported and annual tax rate before non-recurring discrete items due to the timing of excess tax benefits associated with stock option exercises. Also includes a $0.16 EPS benefit for the three months ended December 31, 2022 for the reduction in our annualized effective tax rate to 18.5% for the first three quarters of 2022, and a $0.14 EPS benefit for the three months ended December 31, 2021 for the reduction in our annualized effective tax rate to 19.0% for the first three quarters of 2021. |
-7-